CN Patent
CN113395958A — 基本上无10-溴-卡马西平的可注射卡马西平组合物
Assigned to H Lundbeck AS · Expires 2021-09-14 · 5y expired
What this patent protects
披露了一种包含卡马西平和磺丁基醚‑7‑β‑环糊精的可注射药物组合物,其中所述组合物基本上无10‑溴‑卡马西平。还披露了用于制造所述组合物的方法和用于使用所述组合物治疗疾病的方法。
USPTO Abstract
披露了一种包含卡马西平和磺丁基醚‑7‑β‑环糊精的可注射药物组合物,其中所述组合物基本上无10‑溴‑卡马西平。还披露了用于制造所述组合物的方法和用于使用所述组合物治疗疾病的方法。
Drugs covered by this patent
- Tegretol (carbamazepine) · Novartis AG (originally Geigy)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.